早期宫颈癌低危患者单纯子宫切除术的系统综述
该系统综述纳入21项研究、2662例接受单纯子宫切除术的早期宫颈癌(IA2-IB1期)患者,评估复发与生存结局。结果显示总体死亡率5.5%,IA2期2.7%、IB1期7.3%;与根治性子宫切除术相比,IA2期死亡率无显著差异,但IB1期可能增加死亡风险。研究质量有限,证据等级III-IV。
要点
- 单纯子宫切除术在IA2期及小体积IB1期宫颈癌中结局似乎良好。
- IB1期患者行单纯子宫切除术可能对生存有不良影响。
- 现有研究偏倚风险中高,证据等级有限。
核心结论
- 对IA2期和小体积IB1期宫颈癌,单纯子宫切除术似乎有利,但IB1期可能增加死亡风险。
- 现有研究质量中等,结论受限。
研究设计与样本
- 纳入21项研究:3项随机对照试验、14项回顾性研究、2项前瞻性研究、2个人群数据集。
- 共2662例接受单纯子宫切除术的早期宫颈癌(IA2-IB1期)患者。
主要发现
- 36.1%为IA2期,61.0%为IB1期;96.8%肿瘤≤2 cm;15.4%淋巴血管间隙浸润阳性。
- 71.8%行淋巴结评估,30.7%接受辅助化疗或放疗。
- 常见并发症:淋巴水肿24%、淋巴囊肿22%、尿失禁18.5%。
- 总死亡率5.5%;IA2期2.7%,IB1期7.3%。
- 18项研究比较单纯与根治性子宫切除术:根治组死亡率4.5%,单纯组5.8%;IA2期无显著差异,IB1期单纯组可能增加死亡风险。
关键数值与推荐
- 早期宫颈癌定义为IA2至IB1期。
- 所有研究(包括3项随机对照试验)偏倚风险中至高,证据等级III至IV。
临床怎么用
- 对IA2期及小体积IB1期宫颈癌,可考虑单纯子宫切除术,但需充分评估IB1期患者的生存风险。
- 临床决策应结合肿瘤大小、分期及患者意愿,并告知证据局限性。
局限性
- 纳入研究偏倚风险中至高,证据等级III至IV。
- 研究质量有限,限制结论可靠性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: A systematic review was performed to examine the outcomes of simple hysterectomy for women with low-risk, early-stage cervical cancer. DATA SOURCES: MEDLINE, Embase, Web of Science, and ClinicalTrials.gov were searched from inception until November 4, 2020. STUDY ELIGIBILITY CRITERIA: Original research reporting recurrence or survival outcomes among women with early-stage cervical cancer (defined as stage IA2 to IB1 disease) who were treated with simple hysterectomy. METHODS: Data regarding study characteristics, tumor characteristics, other treatment modalities, adjuvant therapy, recurrence, and survival outcomes were analyzed. Studies that reported both simple hysterectomy and radical hysterectomy outcomes were compared in a subgroup analysis. Summary statistics were reported and eligible studies were further analyzed to determine an estimated hazard ratio comparing simple hysterectomy with radical hysterectomy. RESULTS: A total of 21 studies were included, of which 3 were randomized control trials, 14 retrospective studies, 2 prospective studies, and 2 population-level data sets. The cohort included 2662 women who underwent simple hysterectomy, of which 36.1% had stage IA2 disease and 61.0% stage IB1 disease. Most cases (96.8%) involved tumors of ≤2 cm in size, and 15.4% of cases were lymphovascular space invasion positive. Approximately 71.8% of women who underwent simple hysterectomy had a lymph node assessment, and 30.7% of women underwent adjuvant chemotherapy or radiation. The most common complications described were lymphedema (24%), lymphocysts (22%), and urinary incontinence (18.5%). The total death rate for studies that reported deaths was 5.5%. By stage, there was a 2.7% mortality rate among IA2 disease and a 7.3% mortality rate among IB1 disease. Of note, 18 studies reported outcomes for both simple and radical hysterectomy, with a 4.5% death rate in the radical hysterectomy group and a 5.8% death rate in the simple hysterectomy group. Estimated and reported hazard ratio demonstrated no significant association for mortality between radical and nonradical surgeries for IA2 disease but potentially increased risk of mortality among IB1 disease. All studies had a moderate to high risk of bias, including the 3 randomized control trials. Level of evidence was limited to III to IV. CONCLUSION: The use of less radical surgery for women with stage IA2 and small volume IB1 cervical cancers appears favorable. However, there is concern that simple hysterectomy in women with stage IB1 tumors may adversely impact survival. Overall, the quality of studies available is modest, limiting the conclusions that can be drawn from the available literature.
引用
- Wu J, Logue T, Kaplan SJ, et al. Less radical surgery for early-stage cervical cancer: a systematic review. Am J Obstet Gynecol. 2020. PMID: 33306971. doi:10.1016/j.ajog.2020.11.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。